Brian Terry
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- Biochemical and Molecular Research 11
-
- HIV/AIDS drug development and treatment 17
- Co-authors
- Paul Modrich (4 shared papers)William E. Jack (4 shared papers)Robert A. Rubin (1 shared paper)Richard J. Colonno (4 shared papers)D L Purich (2 shared papers)Anjalie Field (6 shared papers)Moira Hagen (7 shared papers)Mark Krystal (13 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (8 papers)Journal of Biological Chemistry (5 papers)Antiviral Research (4 papers)Proceedings of the National Academy of Sciences (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Brian Terry
35 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 81
- Virology 294
- Infectious Diseases 379
- Molecular Biology 736
- Genetics 230
- Hepatology 55
Countries citing papers authored by Brian Terry
This map shows the geographic impact of Brian Terry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Terry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Terry more than expected).
Fields of papers citing papers by Brian Terry
This network shows the impact of papers produced by Brian Terry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Terry. The network helps show where Brian Terry may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Terry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 155 | |
| 2 | 1985 | 153 | |
| 3 | 2000 | 141 | |
| 4 | 1983 | 130 | |
| 5 | 1996 | 98 | |
| 6 | 1994 | 47 | |
| 7 | 1990 | 44 | |
| 8 | 1980 | 37 | |
| 9 | 1988 | 35 | |
| 10 | 2014 | 34 | |
| 11 | 1988 | 30 | |
| 12 | 1993 | 28 | |
| 13 | 2016 | 26 | |
| 14 | 2008 | 26 | |
| 15 | 2008 | 24 | |
| 16 | 1979 | 24 | |
| 17 | 2016 | 23 | |
| 18 | Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanine. | 1991 | 21 |
| 19 | 1992 | 20 | |
| 20 | 2006 | 19 |
About Brian Terry
Brian Terry is a scholar working on Molecular Biology, Infectious Diseases, Epidemiology, Organic Chemistry and Virology, having authored 35 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (17 papers), Biochemical and Molecular Research (11 papers), Herpesvirus Infections and Treatments (9 papers), HIV Research and Treatment (8 papers), Cytomegalovirus and herpesvirus research (6 papers), Carbohydrate Chemistry and Synthesis (5 papers), Click Chemistry and Applications (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). The work is most often cited by research in Virology (294 citations), Infectious Diseases (379 citations), Molecular Biology (736 citations), Genetics (230 citations) and Hepatology (55 citations). Brian Terry has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Paul Modrich, William E. Jack, Robert A. Rubin, Richard J. Colonno, D L Purich, Anjalie Field, Moira Hagen, Mark Krystal, Christopher Cianci and James T. Matthews. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Antiviral Research, Proceedings of the National Academy of Sciences and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.